These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26585440)

  • 1. DECISION-MAKING ALIGNED WITH RAPID-CYCLE EVALUATION IN HEALTH CARE.
    Schneeweiss S; Shrank WH; Ruhl M; Maclure M
    Int J Technol Assess Health Care; 2015 Jan; 31(4):214-22. PubMed ID: 26585440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early assessment of medical technologies to inform product development and market access: a review of methods and applications.
    Ijzerman MJ; Steuten LM
    Appl Health Econ Health Policy; 2011 Sep; 9(5):331-47. PubMed ID: 21875163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health technology assessment in India: the potential for improved healthcare decision-making.
    Kumar M; Ebrahim S; Taylor FC; Chokshi M; Gabbay J
    Natl Med J India; 2014; 27(3):159-63. PubMed ID: 25668089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austria.
    Feig C; Cheung KL; Hiligsmann M; Evers SMAA; Simon J; Mayer S
    Expert Rev Pharmacoecon Outcomes Res; 2018 Apr; 18(2):223-232. PubMed ID: 28862060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based decision-making 3: Health technology assessment.
    O'Reilly D; Campbell K; Vanstone M; Bowen JM; Schwartz L; Assasi N; Goeree R
    Methods Mol Biol; 2015; 1281():417-41. PubMed ID: 25694325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary survey on the influence of rapid health technology assessments.
    Hailey D
    Int J Technol Assess Health Care; 2009 Jul; 25(3):415-8. PubMed ID: 19619362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coverage with evidence development: the Ontario experience.
    Levin L; Goeree R; Levine M; Krahn M; Easty T; Brown A; Henry D
    Int J Technol Assess Health Care; 2011 Apr; 27(2):159-68. PubMed ID: 21473814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing decision making on therapeutic interventions.
    Lee SM; Kim G; Ahn J; Suh HS; Heo DS
    Int J Technol Assess Health Care; 2013 Jul; 29(3):331-5. PubMed ID: 23863190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health technology assessment.
    Hailey D
    Singapore Med J; 2006 Mar; 47(3):187-92; quiz 193. PubMed ID: 16518551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-criteria development and incorporation into decision tools for health technology adoption.
    Poulin P; Austen L; Scott CM; Waddell CD; Dixon E; Poulin M; Lafrenière R
    J Health Organ Manag; 2013; 27(2):246-65. PubMed ID: 23802401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of HTA research on policy decision-making.
    Youngkong S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S119-26. PubMed ID: 24964709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making.
    Andronis L; Barton P; Bryan S
    Health Technol Assess; 2009 Jun; 13(29):iii, ix-xi, 1-61. PubMed ID: 19500484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of health technology assessment reports on decision making in Austria.
    Zechmeister I; Schumacher I
    Int J Technol Assess Health Care; 2012 Jan; 28(1):77-84. PubMed ID: 22233544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World Data Analytics Fit for Regulatory Decision-Making.
    Schneeweiss S; Glynn RJ
    Am J Law Med; 2018 May; 44(2-3):197-217. PubMed ID: 30106649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying rapid 'de-facto' HTA in resource-limited settings: experience from Romania.
    Lopert R; Ruiz F; Chalkidou K
    Health Policy; 2013 Oct; 112(3):202-8. PubMed ID: 23953877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Conceptual Framework for Life-Cycle Health Technology Assessment.
    Kirwin E; Round J; Bond K; McCabe C
    Value Health; 2022 Jul; 25(7):1116-1123. PubMed ID: 35779939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and test of a decision support tool for hospital health technology assessment.
    Sampietro-Colom L; Morilla-Bachs I; Gutierrez-Moreno S; Gallo P
    Int J Technol Assess Health Care; 2012 Oct; 28(4):460-5. PubMed ID: 23062518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective.
    Xie F; Bowen JM; Sutherland SC; Burke N; Blackhouse G; Tarride JE; O'Reilly D; Goeree R
    Expert Rev Pharmacoecon Outcomes Res; 2011 Oct; 11(5):513-21. PubMed ID: 21958096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.